Illustrative image – not actual.Cipla has announced an investment of around Rs 600 crore in Research & Development (R&D) during this year. The money will be utilised to implement research-oriented projects.
The company has initiated a major expansion of its R&D centre, which includes constructing new buildings and facilities at Vikhroli, in Mumbai.
Cipla's development and regulatory approval processes are moving in the right direction. Presently, there are over 200 development projects underway, indicating a well planned progress. Its R&D expenses increased from 5.1 per cent of its total revenue in FY 2012-13 to 5.4 per cent in FY 2013-14.
Apart from over 90 filings for formulations in Europe and North America in FY 2013-14, the company had more than 1,000 filings in other international markets.
Cipla has bagged over 50 approvals in Europe and North America, along with more than 800 approvals in other international markets.
